The critical functions of DEL-1, its correlation with the neutrophilic response and survival from sepsis and the fact that it is a secreted protein that could be administered in vivo in a controlled manner depending on the clinical situation, render DEL-1 an attractive and promising prognostic and/or therapeutic target in neonatal sepsis. Here, EDIL3 is linked to Sepsis.